Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Clinical trial NCT06014502 · RECRUITING
Trial details
- NCT number
- NCT06014502
- Sponsor
- ImmunoGenesis
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-07
- Primary completion
- 2027-12-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.